Income Tax Expense (Benefit) in USD of INTEGRATED BIOPHARMA INC from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
INTEGRATED BIOPHARMA INC quarterly/annual Income Tax Expense (Benefit) history and change rate from 2011 to Q3 2025.
  • INTEGRATED BIOPHARMA INC Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $73K, a 70.2% decline year-over-year.
  • INTEGRATED BIOPHARMA INC Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $1.08M, a 179% increase year-over-year.
  • INTEGRATED BIOPHARMA INC annual Income Tax Expense (Benefit) for 2025 was $1.25M, a 704% increase from 2024.
  • INTEGRATED BIOPHARMA INC annual Income Tax Expense (Benefit) for 2024 was $156K, a 16.4% increase from 2023.
  • INTEGRATED BIOPHARMA INC annual Income Tax Expense (Benefit) for 2023 was $134K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

INTEGRATED BIOPHARMA INC Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.08M $73K -$172K -70.2% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $1.25M $773K +$627K +429% 01 Apr 2025 30 Jun 2025 10-K 23 Sep 2025
Q1 2025 $627K $167K +$100K +149% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $527K $69K +$139K 01 Oct 2024 31 Dec 2024 10-Q 13 Feb 2025
Q3 2024 $388K $245K +$232K +1785% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 $156K $146K +$103K +240% 01 Apr 2024 30 Jun 2024 10-K 23 Sep 2025
Q1 2024 $53K $67K +$37K +123% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $16K -$70K -$80K -800% 01 Oct 2023 31 Dec 2023 10-Q 13 Feb 2025
Q3 2023 $96K $13K -$38K -74.5% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 $134K $43K +$1.13M 01 Apr 2023 30 Jun 2023 10-K 20 Sep 2024
Q1 2023 -$996K $30K -$133K -81.6% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 -$863K $10K +$350K 01 Oct 2022 31 Dec 2022 10-Q 12 Feb 2024
Q3 2022 -$1.21M $51K +$28K +122% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$1.24M -$1.09M +$666K +38% 01 Apr 2022 30 Jun 2022 10-K 15 Sep 2023
Q1 2022 -$1.91M $163K -$302K -64.9% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$1.61M -$340K -$435K -458% 01 Oct 2021 31 Dec 2021 10-Q 10 Feb 2023
Q3 2021 -$1.17M $23K -$404K -94.6% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$766K -$1.75M -$517K -41.8% 01 Apr 2021 30 Jun 2021 10-K 13 Sep 2022
Q1 2021 -$249K $465K +$398K +594% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$647K $95K -$17K -15.2% 01 Oct 2020 31 Dec 2020 10-Q 10 Feb 2022
Q3 2020 -$630K $427K +$390K +1054% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$1.02M -$1.24M -$1.33M -1361% 01 Apr 2020 30 Jun 2020 10-K 02 Sep 2021
Q1 2020 $314K $67K -$76K -53.1% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $390K $112K +$54K +93.1% 01 Oct 2019 31 Dec 2019 10-Q 12 Feb 2021
Q3 2019 $336K $37K -$18K -32.7% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 $354K $98K +$169K 01 Apr 2019 30 Jun 2019 10-K 23 Sep 2020
Q1 2019 $185K $143K +$40K +38.8% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 $145K $58K -$280K -82.8% 01 Oct 2018 31 Dec 2018 10-Q 12 Feb 2020
Q3 2018 $425K $55K +$99K 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 $326K -$71K 01 Apr 2018 30 Jun 2018 10-K 29 Aug 2019
Q1 2018 $103K +$35K +51.5% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 $338K +$267K +376% 01 Oct 2017 31 Dec 2017 10-Q 13 Feb 2019
Q3 2017 -$44K -$170K -135% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q1 2017 $68K +$14K +25.9% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 $71K +$51K +255% 01 Oct 2016 31 Dec 2016 10-Q 09 Feb 2018
Q3 2016 $126K +$98K +350% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q1 2016 $116K $54K +$30K +125% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q4 2015 $86K $20K -$47K -70.1% 01 Oct 2015 31 Dec 2015 10-Q 10 Feb 2017
Q3 2015 $133K $28K -$1K -3.45% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016
Q2 2015 $134K $14K +$56K 01 Apr 2015 30 Jun 2015 10-K 02 Sep 2016
Q1 2015 $78K $24K -$3K -11.1% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q4 2014 $81K $67K +$6K +9.84% 01 Oct 2014 31 Dec 2014 10-Q 19 Feb 2016
Q3 2014 $75K $29K -$14K -32.6% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015
Q2 2014 $89K -$42K 01 Apr 2014 30 Jun 2014 10-K 04 Sep 2015
Q1 2014 $27K 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015
Q4 2013 $61K 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015
Q3 2013 $43K 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014

INTEGRATED BIOPHARMA INC Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $1.25M +$1.1M +704% 01 Jul 2024 30 Jun 2025 10-K 23 Sep 2025
2024 $156K +$22K +16.4% 01 Jul 2023 30 Jun 2024 10-K 23 Sep 2025
2023 $134K +$1.38M 01 Jul 2022 30 Jun 2023 10-K 20 Sep 2024
2022 -$1.24M -$475K -62% 01 Jul 2021 30 Jun 2022 10-K 15 Sep 2023
2021 -$766K +$254K +24.9% 01 Jul 2020 30 Jun 2021 10-K 13 Sep 2022
2020 -$1.02M -$1.37M -388% 01 Jul 2019 30 Jun 2020 10-K 02 Sep 2021
2019 $354K +$28K +8.59% 01 Jul 2018 30 Jun 2019 10-K 23 Sep 2020
2018 $326K -$71K -17.9% 01 Jul 2017 30 Jun 2018 10-K 29 Aug 2019
2017 $397K +$132K +49.8% 01 Apr 2017 31 Mar 2018 10-Q 09 May 2018
2016 $265K +$131K +97.8% 01 Apr 2016 31 Mar 2017 10-Q 09 May 2018
2015 $134K +$45K +50.6% 01 Jul 2014 30 Jun 2015 10-K 02 Sep 2016
2014 $89K +$72K +424% 01 Jul 2013 30 Jun 2014 10-K 04 Sep 2015
2013 $17K +$6K +54.5% 01 Jul 2012 30 Jun 2013 10-K 08 Sep 2014
2012 $11K -$14K -56% 01 Jul 2011 30 Jun 2012 10-K 30 Sep 2013
2011 $25K 01 Jul 2010 30 Jun 2011 10-K 15 Oct 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.